Results 311 to 320 of about 159,123 (340)
Some of the next articles are maybe not open access.
Cardiovascular disease and neoplasms after pancreas transplantation
The Lancet, 1998Sir—With respect to Edmond Ryan’s April 11 commentary on the clinical indications of pancreas transplantation, we would briefly report our experience. Since 1985 we have enrolled 333 insulin-dependent diabetic patients to the kidney-pancreas transplantation programme: 107 patients received kidney-pancreas (KP) transplantation (25 duct-obstruction [KPS ...
A. Secchi +4 more
+9 more sources
Malignant Neoplasms Following Cardiac Transplantation
JAMA: The Journal of the American Medical Association, 1978Between Jan 6, 1968, and April 11, 1977, 124 patients underwent cardiac transplantation at Stanford University Medical Center, with a mean and median period of follow-up of 18.3 and 9.7 months, respectively. Malignant neoplasms developed in seven patients--three lymphoproliferative neoplasms, two skin cancers, one acute leukemia, and one colon ...
Jeffrey L. Anderson +4 more
openaire +3 more sources
Lymphatic metastasis of transplantable animal neoplasms
Experientia, 1974L'injection de 5 millions de cellules tumorales RD3 dans la patte du rat, fait apparaitre des depots metastasique sous forme de ganglions lymphatiques poplitetaux. L'examen histologique detaille montre qu'ils sont vraies metastases. Des resultats pareils sont apparus dans 2 autres tumeurs qui etaient histologiquement malignes, mais non dans celles qui ...
C. Potter +3 more
openaire +3 more sources
Transplantation for myeloid neoplasms with antecedent solid tumor
Cancer, 2022AbstractBackgroundDefinitive treatment of acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and myeloproliferative neoplasm (MPN) involves allogeneic hematopoietic stem cell transplantation (allo‐HSCT), either with myeloablative (MAC) or reduced‐intensity conditioning (RIC). These diseases may arise in patients with a prior solid tumor. The
Andrew Jay Portuguese +3 more
openaire +2 more sources
Neoplasms and Transplantation — Trading Swords for Plowshares
New England Journal of Medicine, 1997The recent death of former U.S. Senator Paul Tsongas at the age of 55 from complications of bone marrow transplantation was a reminder that we have not cleared this treatment of its most difficult problems. The senator had received two marrow transplants — an autograft in 1986 to treat lymphoma, and an allograft in 1996 to treat the myelodysplastic ...
Robert S. Schwartz, David P. Schenkein
openaire +2 more sources
Malignant Neoplasms Occurring After Cardiac Transplantation
JAMA: The Journal of the American Medical Association, 1983Fifty-seven cardiac transplants in 53 patients have been performed; 30 survived for at least three months. Malignant neoplasms developed in three (10%) of these patients. This incidence is more than double that in recipients of donor kidneys at our institution. Kaposi's sarcoma developed in three patients in the combined groups and accounted for 30% of
Robert Lanza +3 more
openaire +3 more sources
Haploidentical Transplants for Myeloproliferative Neoplasms
2017Allogeneic hematopoietic cell transplantation remains the only curative therapy available for patients with myeloproliferative neoplasms and is mostly performed for primary myelofibrosis or secondary myelofibrosis with high dynamic international scoring system-plus score, advanced (or refractory) chronic myelogenous leukemia, and chronic myelomonocytic
Richard E. Champlin +2 more
openaire +2 more sources
Liver transplantation in malignant primary hepatic neoplasms
The American Journal of Surgery, 1992Between April 1986 and August 1990, 151 liver transplantations were performed at our institution, 16 (11%) of them in 14 patients with primary hepatic tumors. There were 12 hepatocellular carcinomas, 1 angiosarcoma, and 1 Klatskin tumor. None of the tumors was resectable, and there was no preoperative evidence of extrahepatic tumoral extension ...
Juan Carlos Palomo +15 more
openaire +3 more sources
Cutaneous Malignant Neoplasms in Patients With Renal Transplants [PDF]
Archives of Dermatology, 1986 • There is an increased risk of developing cutaneous neoplasms in patients with renal transplants who are receiving immunosuppressive therapy. We studied 523 consecutive white patients who had received renal transplants at a Canadian medical center. Malignant neoplasms developed in 7.5% of these patients, and 72% of these neoplasms were cutaneous in ...
Carl J. Cardella +2 more
openaire +1 more source
Effect of Sex Hormones on Transplanted Neoplasms
The American Journal of Cancer, 1936Introduction In 1931 Bischoff and Maxwell (1) tested the effects of prolan, estrin, and placental and pituitary gonadotropic extracts upon the rate of growth of the R10 tumor, administering physiologically standardized amounts. The results were entirely negative.2 The following year, Zondek, Zondek, and Hartoch (2) showed that excessive doses of ...
L. C. Maxwell, Fritz Bischoff
openaire +2 more sources